Correlation of betel nut chewing and clinicopathologic factors of oral squamous cell carcinoma

doi:10.19439/j.sjos.2021.03.009

Abstract

Abstract: PURPOSE: To investigate the correlation of clinicopathologic factors and immunophenotypic features with betel nut chewing in oral squamous cell carcinoma(OSCC). METHODS: The data of 88 patients with OSCC were collected. According to the habit of betel nut chewing, the clinicopathologic factors and immunohistochemical parameters were analyzed. The relationship between clinicopathologic factors of OSCC and betel nut chewing was analyzed with univariate analysis and multivariate analysis using SPSS 17.0 software package. RESULTS: 46.6% of patients had the habit of betel nut chewing and 67.0% of patients had tongue cancer and buccal cancer. The pathological stages were mainly T2 (40.9%). From univariate analysis of the results, differentiation degree, ki-67, p53 was significantly correlated with the habit of betel nut chewing(P<0.05); while gender, age, location, pathological T stage and cervical lymph node metastasis were not significantly correlated with habit of betel nut chewing (P>0.05). From multivariate analysis of the results, location and differentiation degree were significantly correlated with the habit of betel nut chewing (P<0.05). CONCLUSIONS: ki-67 and p53 protein are lowly expressed in OSCC patients with the habit of betel nut chewing, suggesting that clinicopathologic factors such as the proliferation activity, malignancy, differentiation and prognosis of tumor are much better. Differentiation degree are relatively good in OSCC patients with the habit of betel nut chewing. Cheek and tongue are the most common site of OSCC.

Key words: Betel nut, Oral squamous cell carcinoma, Clinicopathologic factors

CLC Number:

R739.8

SHAO Xiao-jun, ZHU Qiao, LIU You, HAN Xiao-dong, LIN Xiao-zhen, XI Qing. Correlation of betel nut chewing and clinicopathologic factors of oral squamous cell carcinoma[J]. Shanghai Journal of Stomatology, 2021, 30(3): 268-272.

References

[1] Müller S.Update from the 4th Edition of the World Health Organization of head and neck tumours: tumours of the oral cavity and mobile tongue[J]. Head Neck Pathol, 2017, 11(1): 33-40.
[2] Thavarajah R, Ranganathan K.Trends in oral squamous cell carcinoma: Diagnosis for effective, evidence-based treatment 2017[J]. J Oral Maxillofac Pathol, 2017, 21(2): 189-191.
[3] Petersen PE.Oral cancer prevention and control-the approach of the World Health Organization[J]. Oral Oncol, 2009, 45(4-5): 454-460.
[4] Javed F, Chotai M, Mehmood A, et al.Oral mucosal disorders associated with habitual gutka usage: a review[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2010, 109(6): 857-864.
[5] Ray JG, Ganguly M, Rao BS, et al.Clinico-epidemiological profile of oral potentially malignant and malignant conditions among areca nut, tobacco and alcohol users in Eastern India: a hospital based study[J]. J Oral Maxillofac Pathol, 2013, 17(1): 45-50.
[6] 邵小钧, 王金竹, 林小臻, 等. 三亚市居民食用槟榔及相关口腔疾病的流行状况调查[J]. 中国热带医学, 2018, 18(10): 994-998.
[7] Hunt JL.Applications of molecular testing in surgical pathology of the head and neck[J]. Mod Pathol, 2017, 30(s1): S104-S111.
[8] Freudlsperger C, Freier K, Hoffmann J, et al.Ki-67 expression predicts radiosensitivity in oral squamous cell carcinoma[J]. Int J Oral Maxillofac Surg, 2012, 41(8): 965-969.
[9] Pei DS, Qian GW, Tian H, et al.Analysis of human Ki-67 gene promoter and identification of the Sp1 binding sites for Ki-67 transcription[J]. Tumour Biol, 2012,33(1): 257-266.
[10] Niikura N, Masuda S, Kumaki N, et al. Prognostic significance of the Ki67 scoring categories in breast cancer subgroups [J]. Clin Breast Cancer, 2014, 14(5): 323-329. e3.
[11] Zargoun IM, Bingle L, Speight PM.DNA ploidy and cell cycle protein expression in oral squamous cell carcinomas with and without lymph node metastases[J]. J Oral Pathol Med, 2017, 46(9): 738-743.
[12] Nathan CO, Amirghahri N, Rice C, et al.Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients[J]. Laryngoscope, 2002, 112(12): 2129-2140.
[13] Shah NG, Trivedi TI, Tankshali RA, et al.Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis[J]. Head Neck, 2009, 31(12): 1544-1556.
[14] Gao L, Gu W, Zheng J, et al.Clinicopathological and prognostic significance of p27 expression in oral squamous cell carcinoma: a meta-analysis[J]. Int J Biol Markers, 2013, 28(4): e329-e335.
[15] Thambiah LJ, Bindushree RV, Anjum A, et al.Evaluating the expression of p16 and p27 in oral epithelial dysplasias and oral squamous cell carcinoma: a diagnostic marker for carcinogenesis[J]. J Oral Maxillofac Pathol, 2018, 22(1): 59-64.
[16] Monteiro LS, Diniz-Freitas M, Warnakulasuriya S, et al.An immunohistochemical score to predict the outcome for oral squamous cell carcinoma[J]. J Oral Pathol Med, 2018, 47(4): 375-381.
[17] Yen AM, Chen SC, Chen TH.Dose-response relationships of oral habits associated with the risk of oral pre-malignant lesions among men who chew betel quid[J]. Oral Oncol, 2007, 43(7): 634-638.